Clinical trial
Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
NCT00017485 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00017485 |
|---|---|
| Title | Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer |
| Official title | A Phase I Study Of Photodynamic Therapy (PDT) For The Treatment Of Basal Cell Carcinoma (BCC): A Drug/Light Dose Finding Study Utilizing 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A (HPPH-PHOTOCLOR) |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | HPPH |
| Enrollment | 6 |
| Start date | Jan 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: